These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19217816)

  • 21. [Homocysteine and hyperhomocysteinemia].
    Laskowska-Klita T
    Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice.
    Zhou J; Møller J; Danielsen CC; Bentzon J; Ravn HB; Austin RC; Falk E
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1470-6. PubMed ID: 11557674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of osteocytes in mediating bone mineralization during hyperhomocysteinemia.
    Vijayan V; Gupta S
    J Endocrinol; 2017 Jun; 233(3):243-255. PubMed ID: 28507207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine and osteoporotic fracture risk: a potential role for B vitamins.
    Cashman KD
    Nutr Rev; 2005 Jan; 63(1):29-36. PubMed ID: 15730233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis.
    Holstein JH; Herrmann M; Splett C; Herrmann W; Garcia P; Histing T; Klein M; Kurz K; Siebel T; Pohlemann T; Menger MD
    Clin Chem Lab Med; 2010 Jun; 48(6):821-7. PubMed ID: 20345232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
    Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
    Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
    Ventura P; Panini R; Emiliani S; Salvioli G
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Public health control of hyperhomocysteinemia and its consequences].
    Czeizel E; Kalina A
    Orv Hetil; 2003 Oct; 144(40):1981-9. PubMed ID: 14626640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical and biomechanical characterization of hyperhomocysteinemic bone disease in an animal model.
    Massé PG; Boskey AL; Ziv I; Hauschka P; Donovan SM; Howell DS; Cole DE
    BMC Musculoskelet Disord; 2003 Feb; 4():2. PubMed ID: 12597778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental hyperhomocysteinemia disturbs bone metabolism in rats.
    Ozdem S; Samanci S; Tasatargil A; Yildiz A; Sadan G; Donmez L; Herrmann M
    Scand J Clin Lab Invest; 2007; 67(7):748-56. PubMed ID: 17852810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One carbon metabolism and bone homeostasis and remodeling: A review of experimental research and population studies.
    Feigerlova E; Demarquet L; Guéant JL
    Biochimie; 2016 Jul; 126():115-23. PubMed ID: 27086080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation.
    Koh JM; Lee YS; Kim YS; Kim DJ; Kim HH; Park JY; Lee KU; Kim GS
    J Bone Miner Res; 2006 Jul; 21(7):1003-11. PubMed ID: 16813521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease.
    Saito M; Marumo K
    Calcif Tissue Int; 2015 Sep; 97(3):242-61. PubMed ID: 25791570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Daily practice using the guidelines for prevention and treatment of osteoporosis. How do we realize the bone quality in routine practice using Japanese guideline for osteoporosis prevention and treatment?].
    Saito M
    Clin Calcium; 2008 Aug; 18(8):1104-13. PubMed ID: 18677047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
    Saito M
    Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial.
    Herrmann M; Umanskaya N; Traber L; Schmidt-Gayk H; Menke W; Lanzer G; Lenhart M; Peter Schmidt J; Herrmann W
    Clin Chem Lab Med; 2007; 45(12):1785-92. PubMed ID: 18020969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
    Lee SH; Kim MJ; Kim BJ; Kim SR; Chun S; Kim HK; Ryu JS; Kim GS; Lee MC; Chung SJ; Koh JM
    Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-vitamins and bone in health and disease: the current evidence.
    Clarke M; Ward M; Strain JJ; Hoey L; Dickey W; McNulty H
    Proc Nutr Soc; 2014 May; 73(2):330-9. PubMed ID: 24572592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid and vitamin B(12) supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial.
    Keser I; Ilich JZ; Vrkić N; Giljević Z; Colić Barić I
    Nutr Res; 2013 Mar; 33(3):211-9. PubMed ID: 23507227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.